Welcome to LookChem.com Sign In|Join Free
  • or
4-(bromomethyl)-2,6-diphenylpyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

796096-61-2

Post Buying Request

796096-61-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

796096-61-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 796096-61-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,6,0,9 and 6 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 796096-61:
(8*7)+(7*9)+(6*6)+(5*0)+(4*9)+(3*6)+(2*6)+(1*1)=222
222 % 10 = 2
So 796096-61-2 is a valid CAS Registry Number.

796096-61-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(bromomethyl)-2,6-diphenylpyridine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:796096-61-2 SDS

796096-61-2Relevant academic research and scientific papers

Heterocycle substituted carboxylic acids

-

Page/Page column 33, (2010/11/08)

The present invention relates to compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention includ

HETEROCYCLE SUBSTITUTED CARBOXYLIC ACIDS

-

Page 82-83, (2010/02/09)

The present invention relates to compounds and pharmaceutically acceptable salts of formula (I), which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention includ

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 796096-61-2